Public-registry trials using TollB-001 Tablet that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Phase II Study of TollB-001 Tablets in Systemic Sclerosis | Toll Biotech Co. Ltd. (Beijing) | Systemic Sclerosis (SSc) | PHASE2 | 2 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →